MorphoSys

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch MorphoSys and buy or sell other stocks, ETFs, and their options commission-free!

About MOR

MorphoSys AG is a biotechnology companies focusing on fully human antibodies. With its unique technologies, MorphoSys is developing the next generation of antibodies, which can be used to treat diseases and for research and diagnostics purposes. 

CEO
Arkadius Pichota
CEOArkadius Pichota
Employees
Employees
Headquarters
Planegg, Bayern (Bavaria)
HeadquartersPlanegg, Bayern (Bavaria)
Founded
1992
Founded1992
Employees
Employees

MOR Key Statistics

Market cap
2.86B
Market cap2.86B
Price-Earnings ratio
-5.47
Price-Earnings ratio-5.47
Dividend yield
Dividend yield
Average volume
21.06K
Average volume21.06K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$19.50
52 Week high$19.50
52 Week low
$4.19
52 Week low$4.19

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.